Abstract
The purpose of this study was to develop a combination method of wet milling and spray-drying technologies to prepare the solid dispersion and improve the dissolution rate of poorly water-soluble drug candidates. Azilsartan (AZL) was selected as the model drug for its poor water solubility. In the study, AZL-loaded solid dispersion was prepared with polyethylene glycol 6000 (PEG6000) and hydroxypropyl cellulose with super low viscosity (HPC-SL) as stabilizers by using combination of wet grinding and spray-drying methods. The high AZL loading solid dispersion was then characterized by scanning electron microscopy (SEM), differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and Fourier transform infrared spectroscopy (FTIR). Besides, dissolution test was carried out by the paddle method and stability investigation was also conducted. As a result, the dissolution rate of the solid dispersion tablets was found to be greater than conventional tablets, but in close agreement with market tablets. Furthermore, the formulation was shown to be stable at 40 ± 2°C and 75 ± 5% for at least 6 months, owing to its decreased particle size, morphology, and its crystal form. It was concluded that the combination of wet milling and spray-drying approaches to prepare solid dispersion would be a prospective method to improve the dissolution rate of poorly water-soluble drugs.
Similar content being viewed by others
REFERENCES
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2000;50:47–60.
Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12(23–24):1068–75. doi:10.1016/j.drudis.2007.09.005.
Hu J, Ng WK, Dong Y, Shen S, Tan RB. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm. 2011;404(1–2):198–204. doi:10.1016/j.ijpharm.2010.10.055.
Lee M-J, Straubinger RM, Jusko WJ. Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats. Pharm Res. 1995;12:1055–9.
Nassar T, Rom A, Nyska A, Benita S. A novel nanocapsule delivery system to overcome intestinal degradation and drug transport limited absorption of P-glycoprotein substrate drugs. Pharm Res. 2008;25(9):2019–29. doi:10.1007/s11095-008-9585-4.
Sinswat P, Overhoff KA, McConville JT, Johnston KP, Williams 3rd RO. Nebulization of nanoparticulate amorphous or crystalline tacrolimus—single-dose pharmacokinetics study in mice. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2008;69(3):1057–66. doi:10.1016/j.ejpb.2008.01.037.
Viernstein H, Weiss-Greiler P, Wolschann P. Solubility enhancement of low soluble biologically active compounds—temperature and cosolvent dependent inclusion complexation. Int J Pharm. 2003;256(1–2):85–94. doi:10.1016/s0378-5173(03)00065-6.
Chung Y, Cho H. Preparation of highly water soluble tacrolimus derivatives: poly(ethylene glycol) esters as potential prodrugs. Arch Pharm Res. 2004;27:873–83.
Park YJ, Ryu DS, Li DX, Quan QZ, Oh DH, Kim JO, et al. Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate. Arch Pharm Res. 2009;32(6):893–8. doi:10.1007/s12272-009-1611-5.
Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm. 2003;267(1–2):79–91. doi:10.1016/j.ijpharm.2003.07.010.
Joe JH, Lee WM, Park Y-J, Joe KH, Oh DH, Seo YG, et al. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm. 2010;395(1–2):161–6. doi:10.1016/j.ijpharm.2010.05.023.
Ewing AV, Clarke GS, Kazarian SG. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2014;60:64–71. doi:10.1016/j.ejps.2014.05.001.
Lust A, Strachan CJ, Veski P, Aaltonen J, Heinamaki J, Yliruusi J, et al. Amorphous solid dispersions of piroxicam and Soluplus((R)): qualitative and quantitative analysis of piroxicam recrystallization during storage. Int J Pharm. 2015;486(1–2):306–14. doi:10.1016/j.ijpharm.2015.03.079.
Mehanna MM, Motawaa AM, Samaha MW. In sight into tadalafil-block copolymer binary solid dispersion: mechanistic investigation of dissolution enhancement. Int J Pharm. 2010;402(1–2):78–88. doi:10.1016/j.ijpharm.2010.09.024.
Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, et al. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm. 2012;422(1–2):202–10. doi:10.1016/j.ijpharm.2011.10.053.
Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2006;64(2):200–5. doi:10.1016/j.ejpb.2006.04.001.
Agrawal AM, Dudhedia MS, Zimny E. Hot melt extrusion: development of an amorphous solid dispersion for an insoluble drug from mini-scale to clinical scale. AAPS PharmSciTech. 2015. doi:10.1208/s12249-015-0425-7.
Takahashi H, Chen R, Okamoto H, Danjo K. Acetaminophen particle design using chitosan and a spray-drying technique. Chem Pharm Bull. 2005;53:37–41.
Ojima M, Igata H, Tanaka M, Sakamoto H, Kuroita T, Kohara Y, et al. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J Pharmacol Exp Ther. 2011;336(3):801–8. doi:10.1124/jpet.110.176636.
Weltman R, Brands CMJ, Corral E, Desmares-Koopmans MJE, Migchielsen MHJ, Oudhoff KA, et al. Assessment of the environmental fate and effects of azilsartan, a selective antagonist of angiotensin II type 1. Chemosphere. 2012;87(11):1323–9. doi:10.1016/j.chemosphere.2012.01.053.
Gong C, Wang J, Sun Y, Ding D, Zhong L, Zhu M, et al. UPLC–MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study. Asian J Pharm Sci. 2015;10(3):247–53. doi:10.1016/j.ajps.2014.10.004.
Liu P, De Wulf O, Laru J, Heikkila T, van Veen B, Kiesvaara J, et al. Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions. AAPS PharmSciTech. 2013;14(2):748–56. doi:10.1208/s12249-013-9960-2.
Kougoulos E, Smales I, Verrier HM. Towards integrated drug substance and drug product design for an active pharmaceutical ingredient using particle engineering. AAPS PharmSciTech. 2011;12(1):287–94. doi:10.1208/s12249-011-9582-5.
Ye X, Patil H, Feng X, Tiwari RV, Lu J, Gryczke A, et al. Conjugation of hot-melt extrusion with high-pressure homogenization: a novel method of continuously preparing nanocrystal solid dispersions. AAPS PharmSciTech. 2015. doi:10.1208/s12249-015-0389-7.
Gilani K, Najafabadi AR, Barghi M, Rafiee-Tehrani M. Aerosolisation of beclomethasone dipropionate using spray dried/lactose/polyethylene glycol carriers. Eur J Pharm Biopharm. 2004;58:595–606. doi:10.1016/j.ejpb.2004.04.011.
Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, et al. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2010;40(4):325–34. doi:10.1016/j.ejps.2010.04.006.
Xu Y, Liu X, Lian R, Zheng S, Yin Z, Lu Y, et al. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid–base neutralization. Int J Pharm. 2012;438(1–2):287–95. doi:10.1016/j.ijpharm.2012.09.020.
Yang M, He S, Fan Y, Wang Y, Ge Z, Shan L, et al. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo. Int J Pharm. 2014;475(1–2):97–109. doi:10.1016/j.ijpharm.2014.08.047.
Celebi H, Kurt A. Effects of processing on the properties of chitosan/cellulose nanocrystal films. Carbohydr Polym. 2015;133:284–93. doi:10.1016/j.carbpol.2015.07.007.
Sonali D, Tejal S, Vaishali T, Tejal G. Silymarin-solid dispersions: characterization and influence of preparation methods on dissolution. Acta Pharma. 2010;60(4):427–43. doi:10.2478/v10007-010-0038-3.
Morakul B, Suksiriworapong J, Chomnawang MT, Langguth P, Junyaprasert VB. Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2014;88(3):886–96. doi:10.1016/j.ejpb.2014.08.013.
ACKNOWLEDGMENTS
The authors gratefully acknowledge financial support from the Science and technology research project of Education Department of Liaoning Province (L2013390).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Lu, T., Sun, Y., Ding, D. et al. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies. AAPS PharmSciTech 18, 473–480 (2017). https://doi.org/10.1208/s12249-016-0531-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0531-1